Sign up to see all 5.
Sign up to see all 5.
Sign up to see all 5.
Every notice on Red Flags →A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
B
BlackRock, Inc.
|
3.0M | 3.33% | +2.2M (+273.9%) | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding3.0M (Q2'26)
Change over 8 quarters+1.4M
Share of the company3.330%
|
||||||
|
VC
Vanguard Capital Management LLC
|
2.2M | 2.42% | +201.5K (+10.2%) | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding2.2M (Q2'26)
Change over 8 quarters+2.2M
Share of the company2.420%
|
||||||
28 more super investors behind a free account
See every manager holding GALECTIN THERAPEUTICS INC, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$7.06M | 1.5M | 1.70% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$4.41M | 951.5K | 1.06% | 0.01% | June 30, 2026 |
23 more funds behind a free account
See every fund holding GALECTIN THERAPEUTICS INC and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
RE
Richard E. Uihlein
5%+ holder
13D · 49.3%
|
54.7M | 61.01% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
CJ
Czirr James C
Insider
|
47.1M | 52.55% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company52.550%
|
||||||
7 more holders behind a free account
See every insider and 5%+ holder of GALECTIN THERAPEUTICS INC.
Sign up freeLoading...